Nicholas Bullock

WCAT Fellow in Urology

School of Medicine

: bullocknp@cardiff.ac.uk

Mr Bullock is a Welsh Clinical Academic Track Fellow and Spedialist Registrar in Urology. He is currently undertaking a PhD at the European Cancer Stem Cell Research Institute exploring the role of Poly ADP-ribose polymerase in advanced prostate cancer. His research is funded by a Urology Foundation Research Scholarship and The John Black Charitable Foundation.

Mr Bullock undertook his undergraduate medical training at Cardiff University (MBBCh) and Imperial College London (Intercalated BSc). After qualifying he completed a two year Academic Foundation Programme in Bristol, followed by urology themed Core Surgical Training in the Wales Deanery. In August 2017 he commenced a Welsh Clinical Academic Track Fellowship in Urology.

2020

Turnham, D. J.et al. 2020. The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells 9(11), article number: 2342. (10.3390/cells9112342)
Bullock, N.et al. 2020. Establishing a national high fidelity cadaveric emergency urology simulation course to increase trainee preparedness for independent on-call practice: a prospective observational study. BMC Medical Education 20(1), article number: 349. (10.1186/s12909-020-02268-1)
Minto, T.et al. 2020. Asymptomatic bilateral obstructing ureteric calculi resulting in Lactobacillaemia and endocarditis requiring emergency aortic valve replacement. Urology Case Reports 32, article number: 101218. (10.1016/j.eucr.2020.101218)
Mainwaring, A.et al. 2020. The top 100 most cited manuscripts in bladder cancer: A bibliometric analysis (review article). International Journal of Surgery 75, pp. 130-138. (10.1016/j.ijsu.2020.01.128)

2019

Bullock, N.et al. 2019. Pathological upgrading in prostate cancer treated with surgery in the United Kingdom: trends and risk factors from the British Association of Urological Surgeons Radical Prostatectomy Registry. BMC Urology 19(1), pp. -., article number: 94. (10.1186/s12894-019-0526-9)
Bullock, N., Serag, H. and Kynaston, H. 2019. Radical open surgery for management of extensive extra-prostatic benign prostatic hyperplasia. Journal of Clinical Urology 12(5), pp. 398-400. (10.1177/2051415818767181)
McLean, K.et al. 2019. Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre observational study. British Journal of Anaesthesia 122(1), pp. 42-50. (10.1016/j.bja.2018.07.029)

2018

Bullock, N.et al. 2018. The 100 most influential manuscripts in andrology: a bibliometric analysis. Basic and Clinical Andrology 28(15) (10.1186/s12610-018-0080-4)
Bullock, N., Steggall, M. and Brown, G. 2018. Emergency management of priapism in the United Kingdom: a survey of current practice. Journal of Sexual Medicine 15(4), pp. 476-479. (10.1016/j.jsxm.2018.01.013)

2017

Bullock, N.et al. 2017. Malakoplakia of the urinary tract mimicking locally advanced malignancy. Journal of Clinical Urology 10(3), pp. 316-318. (10.1177/2051415817691661)
Bullock, N. and Oltean, S. 2017. The many faces of SRPK1. The Journal of Pathology 241(4), pp. 437-440. (10.1002/path.4846)
Ellul, T.et al. 2017. The 100 most cited manuscripts in emergency abdominal surgery: a bibliometrics analysis. International Journal of Surgery 37, pp. 29-35. (10.1016/j.ijsu.2016.12.006)
Drake, T. M.et al. 2017. Safety of nonsteroidal anti-inflammatory drugs in major gastrointestinal surgery: a prospective, multicenter cohort study. World Journal of Surgery 41(1), pp. 47-55. (10.1007/s00268-016-3727-3)

2016

Bullock, N., Wallis, S. and Ved, R. 2016. Invest to progress? a survey of the cost of postgraduate training prior to specialty applications in the United Kingdom. British Journal of Medicine and Medical Research 17(7), pp. 1-7. (10.9734/BJMMR/2016/28382)
Drake, T. M.et al. 2016. Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery. British Journal of Surgery 103(9), pp. 1157-1172. (10.1002/bjs.10203)
Bullock, N.et al. 2016. Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion. Journal of Clinical Pathology 69(2), pp. 171-175. (10.1136/jclinpath-2015-203125)